BDTX: SEC Form 10-Q filed by Black Diamond Therapeutics Inc.
Alpha Vantage · Quantisnow · · AI-summarised by FinFlash
Black Diamond Therapeutics filed its SEC Form 10-Q, reporting a nine-month net loss of $29.0 million, reversing a $37.5 million net income in the prior year that was largely driven by a $70 million Servier upfront payment in 2025. The filing also details an accumulated deficit.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.